热门资讯> 正文

aTyr Pharma GAAP每股收益为-0.14美元，击败0.02美元

2026-03-06 14:24

aTyr Pharma(ATYR) 0

aTyr Pharma press release (ATYR): Q4 GAAP EPS of -$0.14 beats by $0.02.
Ended 2025 with $80.9 million in cash, cash equivalents, restricted cash and investments.

More on aTyr Pharma

aTyr Pharma to meet FDA in April to discuss lead asset
Seeking Alpha’s Quant Rating on aTyr Pharma
Historical earnings data for aTyr Pharma
Financial information for aTyr Pharma

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。